GGrantIndex
← Leaderboards

Anita Borton Hjelmeland

Cleveland Clinic Lerner Com-Cwru

$6,940,856
Attributed
$11,102,747
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY201025
$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,102,747 · 8

By mechanism

R01$5,101,194 · 3
U01$4,772,905 · 1
R21$537,229 · 1
R03$354,954 · 2
T32$336,465 · 1

Most similar at Cleveland Clinic Lerner Com-Cwru

Same institution · by research overlap

Others in their field

Top investigators on “Brain Neoplasms

Research focus

Brain NeoplasmsGrowthGlioblastomaTemozolomidePhenotypeSignal TransductionNeoplastic CellTumorMalignant NeoplasmsGliomaXenograft ProcedureTumor GrowthTherapy ResistantCellsBiologicalIn VitroGeneticPropertyMediatingAdultMolecularIn VivoRadiation TherapyCancer Biology

Grant awards (29)

Sialylation in the Maintenance and Metabolic Plasticity of Neural Stem Cell-Like Brain Tumor Cells$488,076
R01 · FY2025 · NS · contact PI
Training Program in Brain Tumor Biology$166,524
T32 · FY2025 · NS · contact PI
Sialylation in the Maintenance and Metabolic Plasticity of Neural Stem Cell-Like Brain Tumor Cells$475,857
R01 · FY2024 · NS · contact PI
Training Program in Brain Tumor Biology$169,941
T32 · FY2024 · NS · contact PI
Sialylation in the Maintenance and Metabolic Plasticity of Neural Stem Cell-Like Brain Tumor Cells$492,216
R01 · FY2023 · NS · contact PI
Targeting Acid Ceramidase to Improve the Efficacy of Herpes Oncolytic Virus$72,696
R03 · FY2023 · NS · contact PI
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress$702,000
U01 · FY2022 · CA
Sialylation in the Maintenance and Metabolic Plasticity of Neural Stem Cell-Like Brain Tumor Cells$506,014
R01 · FY2022 · NS · contact PI
Biosynthetic Metabolic Pathway Regulation of Glioma Growth$379,306
R01 · FY2022 · NS · contact PI
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress$333,751
U01 · FY2022 · CA
Targeting Acid Ceramidase to Improve the Efficacy of Herpes Oncolytic Virus$141,129
R03 · FY2022 · NS · contact PI
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress$790,576
U01 · FY2021 · CA
Biosynthetic Metabolic Pathway Regulation of Glioma Growth$379,306
R01 · FY2021 · NS · contact PI
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress$333,751
U01 · FY2021 · CA
Novel Mouse Models to Understand ST6Gal1-Mediated Sialylation Effects in the Developing and Pathologic Brain$141,129
R03 · FY2021 · NS · contact PI
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress$827,700
U01 · FY2020 · CA
Biosynthetic Metabolic Pathway Regulation of Glioma Growth$379,306
R01 · FY2020 · NS · contact PI
Glioblastoma tumor microenvironmental influence on acquired and inherent cancer therapy resistance.$297,715
U01 · FY2020 · CA
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress$746,835
U01 · FY2019 · CA
Biosynthetic Metabolic Pathway Regulation of Glioma Growth$379,651
R01 · FY2019 · NS · contact PI
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress$740,577
U01 · FY2018 · CA
Biosynthetic Metabolic Pathway Regulation of Glioma Growth$403,333
R01 · FY2018 · NS · contact PI
Identification of Glucose Transporter 3 Inhibitors for Glioblastoma Treatment$272,552
R21 · FY2017 · NS · contact PI
Identification of Glucose Transporter 3 Inhibitors for Glioblastoma Treatment$264,677
R21 · FY2016 · NS · contact PI
A20 Promotes Glioma Stem Cell Mediated Tumorigenesis$229,598
R01 · FY2014 · CA · contact PI
A20 Promotes Glioma Stem Cell Mediated Tumorigenesis$222,309
R01 · FY2013 · CA · contact PI
A20 Promotes Glioma Stem Cell Mediated Tumorigenesis$252,801
R01 · FY2012 · CA · contact PI
A20 Promotes Glioma Stem Cell Mediated Tumorigenesis$252,801
R01 · FY2011 · CA · contact PI
A20 Promotes Glioma Stem Cell Mediated Tumorigenesis$260,620
R01 · FY2010 · CA · contact PI